These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 27986755)

  • 1. Impact of Incomplete Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Nagaraja V; Ooi SY; Nolan J; Large A; De Belder M; Ludman P; Bagur R; Curzen N; Matsukage T; Yoshimachi F; Kwok CS; Berry C; Mamas MA
    J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27986755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies.
    Garcia S; Sandoval Y; Roukoz H; Adabag S; Canoniero M; Yannopoulos D; Brilakis ES
    J Am Coll Cardiol; 2013 Oct; 62(16):1421-31. PubMed ID: 23747787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized Trials.
    Elgendy IY; Mahmoud AN; Kumbhani DJ; Bhatt DL; Bavry AA
    JACC Cardiovasc Interv; 2017 Feb; 10(4):315-324. PubMed ID: 28231899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the optimal approach to a non- culprit stenosis after ST-elevation myocardial infarction - Conservative therapy or upfront revascularization? An updated meta-analysis of randomized trials.
    Anantha Narayanan M; Reddy YN; Sundaram V; Reddy YN; Baskaran J; Agnihotri K; Badheka A; Patel N; Deshmukh A
    Int J Cardiol; 2016 Aug; 216():18-24. PubMed ID: 27135152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete revascularization for patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: a meta-analysis of randomized trials.
    Bajraktari G; Jashari H; Ibrahimi P; Alfonso F; Jashari F; Ndrepepa G; Elezi S; Henein MY
    Coron Artery Dis; 2018 May; 29(3):204-215. PubMed ID: 29346126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes With Complete Versus Incomplete Revascularization in Patients With Multivessel Coronary Disease Undergoing Percutaneous Coronary Intervention With Everolimus Eluting Stents.
    Bangalore S; Guo Y; Samadashvili Z; Hannan EL
    Am J Cardiol; 2020 Feb; 125(3):362-369. PubMed ID: 31810515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
    Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: a meta-analysis of randomized trials.
    Xu H; Zhang X; Li J; Liu H; Hu X; Yang J
    BMC Cardiovasc Disord; 2019 Apr; 19(1):91. PubMed ID: 31010423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Approaches to Revascularization in Patients With Multivessel Coronary Artery Disease Presenting With ST-Segment Elevation Myocardial Infarction: Meta-analyses of Randomized Control Trials.
    Bajaj NS; Kalra R; Aggarwal H; Ather S; Gaba S; Arora G; McGiffin DC; Ahmed M; Aslibekyan S; Arora P
    J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26667087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-Analysis Comparing Same-Sitting and Staged Percutaneous Coronary Intervention of Non-Culprit Artery for ST-Elevation Myocardial Infarction with Multivessel Coronary Disease.
    Ueyama H; Kuno T; Yasumura K; Vengrenyuk Y; Takagi H; Barman N; Suleman J; Banning AS; Boxma-de Klerk BM; Smits PC; Kini A; Sharma SK
    Am J Cardiol; 2021 Jul; 150():24-31. PubMed ID: 34011437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis.
    Bainey KR; Mehta SR; Lai T; Welsh RC
    Am Heart J; 2014 Jan; 167(1):1-14.e2. PubMed ID: 24332136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents.
    Chang M; Ahn JM; Kim N; Lee PH; Roh JH; Yoon SH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    Am Heart J; 2016 Sep; 179():157-65. PubMed ID: 27595691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term outcomes of new generation drug eluting stents versus coronary artery bypass grafting for multivessel and/or left main coronary artery disease. A Bayesian network meta-analysis of randomized controlled trials.
    Mina GS; Watti H; Soliman D; Shewale A; Atkins J; Reddy P; Dominic P
    Cardiovasc Revasc Med; 2018 Sep; 19(6):671-678. PubMed ID: 29396239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete versus culprit-only revascularization during primary percutaneous coronary intervention in ST-elevation myocardial infarction patients with multivessel disease: a meta-analysis.
    Lu C; Huang H; Li J; Zhao J; Zhang Q; Zeng Z; Chen Y
    Kaohsiung J Med Sci; 2013 Mar; 29(3):140-9. PubMed ID: 23465417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everolimus Eluting Stents Versus Coronary Artery Bypass Graft Surgery for Patients With Diabetes Mellitus and Multivessel Disease.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    Circ Cardiovasc Interv; 2015 Jul; 8(7):e002626. PubMed ID: 26156152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-Analysis Comparing Complete Revascularization Versus Infarct-Related Only Strategies for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease.
    Shah R; Berzingi C; Mumtaz M; Jasper JB; Goswami R; Morsy MS; Ramanathan KB; Rao SV
    Am J Cardiol; 2016 Nov; 118(10):1466-1472. PubMed ID: 27642115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved long-term survival for diabetic patients with surgical versus interventional revascularization.
    Kurlansky P; Herbert M; Prince S; Mack MJ
    Ann Thorac Surg; 2015 Apr; 99(4):1298-305. PubMed ID: 25686668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of fractional flow reserve guided complete revascularization versus infarct related artery only revascularization in patients with ST-elevation myocardial infarction and multivessel coronary artery disease.
    Neupane S; Singh H; Edla S; Altujjar M; Yamsaki H; Lalonde T; Rosman HS; Eggebrecht H; Mehta RH
    Coron Artery Dis; 2019 Sep; 30(6):393-397. PubMed ID: 31094897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staged Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis.
    Villablanca PA; Olmedo W; Weinreich M; Gupta T; Mohananey D; Albuquerque FN; Kassas I; Briceño D; Sanina C; Brevik TA; Ong E; Ramakrishna H; Attubato M; Menegus M; Wiley J; Kalra A
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29654206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.